Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04162873 · ClinicalTrials.gov registry record · Phase 2
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
A Phase 2 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT04162873 is a Phase 2 study that was terminated before completion, run by University of Utah. The registered enrollment target is 13 participants.
The verdict
NCT04162873, a Phase 2 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
This phase II trial studies how well celecoxib works through surgery and radiation therapy in treating patients with head and neck cancer that has spread to other places in the body (advanced). Celecoxib is Food and Drug Administration approved to treat arthritis, acute pain, and painful menstrual periods. Adding celecoxib to standard of care treatment may help to decrease the amount of time between surgery and radiation therapy.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Placebo
- OTHER Questionnaire Administration
- DRUG Celecoxib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-11-27 |
| Est. Completion | 2023-04-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04162873
The ClinicalTrials.gov registry entry for NCT04162873 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04162873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04162873 about?
NCT04162873 is a clinical study titled "Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer". This phase II trial studies how well celecoxib works through surgery and radiation therapy in treating patients with head and neck cancer that has spread to other places in the body (advanced). Celecoxib is Food and Drug Administration approved to treat arthritis, acute pain, and painful menstrual p...
What is the current status of trial NCT04162873?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2019-11-27. Estimated completion is 2023-04-26.
What interventions are being tested in trial NCT04162873?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Placebo (OTHER), Questionnaire Administration (OTHER), Celecoxib (DRUG).
Who is sponsoring clinical trial NCT04162873?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.